Cue Biopharma, Inc. (CUE) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 5.69M | 21.94M | 2.15M | 2.95M | 421K | 1.58M | 3.34M | 2.66M | 1.72M | 1.82M | 2.1M | 1.38M | 187K | 151K | 68K | 26K | 1M | 8.25M | 2.4M | 2.74M |
| Revenue Growth % | 1250.59% | 1292.26% | -35.58% | 11.14% | -75.48% | -13.45% | 58.86% | 92.33% | 818.18% | 1105.96% | 2988.24% | 5215.38% | -81.3% | -98.17% | -97.16% | -99.05% | -35.61% | 1636.57% | 240.2% | 154.79% |
| Cost of Goods Sold | 0 | 0 | 79K | 0 | 0 | 0 | 0 | 0 | 0 | 13.49M | 8.97M | 0 | 0 | 8.05M | 7.57M | 9.59M | 10.08M | 11.5M | 11.29M | 8.76M |
| COGS % of Revenue | - | - | 3.68% | - | - | - | - | - | - | 740.64% | 427.33% | - | - | 5330.46% | 11133.82% | 36892.31% | 1008.2% | 139.33% | 471.32% | 319.9% |
| Gross Profit | 5.69M | 21.94M | 2.07M | 2.95M | 421K | 1.58M | 3.34M | 2.66M | 1.72M | -11.67M | -6.87M | 1.38M | 187K | -7.9M | -7.5M | -9.57M | -9.08M | -3.25M | -8.89M | -6.02M |
| Gross Margin % | 100% | 100% | 96.32% | 100% | 100% | 100% | 100% | 100% | 100% | -640.64% | -327.33% | 100% | 100% | -5230.46% | -11033.82% | -36792.31% | -908.2% | -39.33% | -371.32% | -219.9% |
| Gross Profit Growth % | 1250.59% | 1292.26% | -37.95% | 11.14% | -75.48% | 113.51% | 148.53% | 92.33% | 818.18% | -47.71% | 8.38% | 114.45% | 102.06% | -143.29% | 15.63% | -58.82% | -9.91% | 56.88% | -30.53% | 14.49% |
| Operating Expenses | 11.05M | 19.98M | 9.61M | 11.59M | 12.72M | 11.21M | 12.15M | 13.04M | 14.38M | 2.17M | 4.54M | 14.9M | 13.57M | 6.97M | 3.53M | 3.52M | 5.16M | 4.65M | 4.13M | 4.28M |
| OpEx % of Revenue | 194.32% | 91.08% | 447.37% | 392.32% | 3021.38% | 711.23% | 364.24% | 490.63% | 837.8% | 118.95% | 216.43% | 1078.08% | 7255.08% | 4614.57% | 5188.24% | 13553.85% | 515.6% | 56.29% | 172.23% | 156.26% |
| Selling, General & Admin | 4.15M | 3.45M | 4.93M | 3.67M | 4.17M | 4.02M | 2.87M | 3.51M | 3.34M | 2.01M | 4.54M | 4.25M | 4.18M | 6.99M | 3.53M | 3.78M | 5.16M | 4.65M | 4.13M | 4.28M |
| SG&A % of Revenue | 73.02% | 15.73% | 229.32% | 124.41% | 991.21% | 255.14% | 85.94% | 132.09% | 194.35% | 110.32% | 216.43% | 307.45% | 2233.16% | 4627.15% | 5188.24% | 14546.15% | 515.6% | 56.29% | 172.23% | 156.26% |
| Research & Development | 6.9M | 16.53M | 4.69M | 7.91M | 8.55M | 7.18M | 9.38M | 9.53M | 10.2M | 10.89M | 9.87M | 10.65M | 9.39M | 11.33M | 7.57M | 9.59M | 10.08M | 11.5M | 11.29M | 8.76M |
| R&D % of Revenue | 121.3% | 75.34% | 218.05% | 267.77% | 2030.17% | 455.84% | 281.21% | 358.54% | 594% | 597.86% | 470.19% | 770.62% | 5021.93% | 7504.64% | 11133.82% | 36892.31% | 1008.2% | 139.33% | 471.32% | 319.9% |
| Other Operating Expenses | 0 | 0 | 0 | 4K | 0 | 4K | -97K | 0 | 849K | -1000K | -1000K | 0 | 0 | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -5.36M | 1.96M | -7.54M | -8.63M | -12.3M | -9.63M | -8.81M | -10.38M | -12.67M | -13.83M | -11.42M | -13.52M | -13.38M | -14.87M | -11.03M | -13.09M | -14.24M | -7.89M | -13.02M | -10.3M |
| Operating Margin % | -94.32% | 8.92% | -351.05% | -292.32% | -2921.38% | -611.23% | -264.24% | -390.63% | -737.8% | -759.58% | -543.76% | -978.08% | -7155.08% | -9845.03% | -16222.06% | -50346.15% | -1423.8% | -95.62% | -543.55% | -376.16% |
| Operating Income Growth % | 56.39% | 120.33% | 14.42% | 16.84% | 2.91% | 30.36% | 22.8% | 23.19% | 5.32% | 6.96% | -3.52% | -3.26% | 6.03% | -88.34% | 15.26% | -27.05% | -13.74% | 28.08% | -28.5% | 5.84% |
| EBITDA | -4.43M | 3.16M | -7.46M | -7.84M | -11.42M | -9.54M | -7.94M | -9.52M | -11.82M | -13.72M | -11.29M | -12.67M | -12.5M | -14.66M | -10.83M | -12.88M | -13.94M | -7.58M | -12.7M | -9.99M |
| EBITDA Margin % | -77.98% | 14.42% | -347.37% | -265.37% | -2711.88% | -605.01% | -237.95% | -358.05% | -688.35% | -753.38% | -537.57% | -916.64% | -6684.49% | -9710.6% | -15926.47% | -49519.23% | -1393.5% | -91.87% | -530.35% | -364.7% |
| EBITDA Growth % | 61.16% | 133.18% | 5.96% | 17.63% | 3.4% | 30.5% | 29.68% | 24.87% | 5.45% | 6.44% | -4.24% | 1.61% | 10.3% | -93.36% | 14.74% | -28.89% | -14.22% | 29.27% | -28.8% | 6.38% |
| D&A (Non-Cash Add-back) | 929K | 1.21M | 79K | 796K | 882K | 98K | 877K | 866K | 849K | 113K | 130K | 849K | 880K | 203K | 201K | 215K | 303K | 309.66K | 316K | 314K |
| EBIT | -5.17M | 2.14M | -7.37M | -8.44M | -12.13M | -9.34M | -8.47M | -9.96M | -12.11M | -13.68M | -11.42M | -12.95M | -12.74M | -14.88M | -11.03M | -13.35M | -14.24M | -7.89M | -13.02M | -10.3M |
| Net Interest Income | 175K | 107K | 147K | 153K | 42K | 137K | 155K | 212K | 321K | 398K | 414K | 332K | 271K | 273.43K | 76K | -118K | -17K | 3.9K | 25K | 24K |
| Interest Income | 179K | 158K | 222K | 198K | 170K | 290K | 343K | 427K | 562K | 905K | 700K | 564K | 641K | 632.24K | 200K | 88K | 8K | 3.9K | 25K | 24K |
| Interest Expense | 4K | 51K | 75K | 45K | 128K | 153K | 188K | 215K | 241K | 507K | 286K | 232K | 370K | 358.81K | 124K | 206K | 25K | 0 | 0 | 0 |
| Other Income/Expense | 185K | 127K | 96K | 153K | 42K | 137K | 155K | 212K | 321K | 398K | 414K | 332K | 271K | 274K | 76K | -118K | -17K | 3.9K | 25K | 24K |
| Pretax Income | -5.18M | 2.08M | -7.45M | -8.48M | -12.26M | -9.5M | -8.66M | -10.17M | -12.35M | -13.43M | -11.01M | -13.19M | -13.11M | -14.59M | -10.96M | -13.21M | -14.26M | -7.89M | -12.99M | -10.28M |
| Pretax Margin % | -91.07% | 9.5% | -346.58% | -287.14% | -2911.4% | -602.54% | -259.59% | -382.66% | -719.1% | -737.73% | -524.05% | -954.05% | -7010.16% | -9663.58% | -16110.29% | -50800% | -1425.5% | -95.58% | -542.51% | -375.28% |
| Income Tax | 0 | 500K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 495K | 0 | 0 |
| Effective Tax Rate % | 0% | 23.98% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -6.27% | 0% | 0% |
| Net Income | -5.18M | 1.58M | -7.45M | -8.48M | -12.26M | -9.5M | -8.66M | -10.17M | -12.35M | -13.43M | -11.01M | -13.19M | -13.11M | -14.59M | -10.96M | -13.21M | -14.26M | -8.38M | -12.99M | -10.28M |
| Net Margin % | -91.07% | 7.22% | -346.58% | -287.14% | -2911.4% | -602.54% | -259.59% | -382.66% | -719.1% | -737.73% | -524.05% | -954.05% | -7010.16% | -9663.58% | -16110.29% | -50800% | -1425.5% | -101.57% | -542.51% | -375.28% |
| Net Income Growth % | 57.75% | 116.69% | 14% | 16.61% | 0.73% | 29.31% | 21.31% | 22.86% | 5.81% | 7.94% | -0.46% | 0.17% | 8.04% | -74.04% | 15.69% | -28.49% | -13.99% | 24.49% | -29.53% | 5.11% |
| Net Income (Continuing) | -5.18M | 1.58M | -7.45M | -8.48M | -12.26M | -9.5M | -8.66M | -10.17M | -12.35M | -13.43M | -11.01M | -13.19M | -13.11M | -14.59M | -10.96M | -13.21M | -14.26M | -8.38M | -12.99M | -10.28M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.08 | 0.43 | -2.21 | -2.66 | -5.10 | -3.90 | -5.10 | -6.00 | -7.50 | -8.40 | -7.20 | -8.70 | -9.00 | -11.10 | -9.30 | -11.40 | -13.20 | -8.10 | -12.30 | -9.90 |
| EPS Growth % | 78.82% | 111.03% | 56.59% | 55.6% | 32% | 53.57% | 29.17% | 31.03% | 16.67% | 24.32% | 22.58% | 23.68% | 31.82% | -37.04% | 24.39% | -15.15% | -7.32% | 27.03% | -20.59% | 13.16% |
| EPS (Basic) | -1.08 | 0.44 | -2.21 | -2.66 | -5.10 | -3.90 | -5.10 | -6.00 | -7.50 | -8.40 | -7.20 | -8.70 | -9.00 | -11.10 | -9.30 | -11.40 | -13.20 | -8.10 | -12.30 | -9.90 |
| Diluted Shares Outstanding | 4.81M | 3.68M | 3.36M | 3.18M | 2.48M | 2.47M | 1.71M | 1.67M | 1.65M | 1.57M | 1.55M | 1.49M | 1.49M | 1.31M | 1.18M | 1.18M | 1.09M | 1.05M | 1.04M | 1.04M |
| Basic Shares Outstanding | 4.81M | 3.6M | 3.36M | 3.18M | 2.48M | 2.47M | 1.71M | 1.67M | 1.65M | 1.57M | 1.55M | 1.49M | 1.49M | 1.31M | 1.18M | 1.18M | 1.09M | 1.05M | 1.04M | 1.04M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |